# Clinical Data Approval Blocker

Status: external governance blocker verified 2026-08-03.

The supplied source inventory contains zero production-approved rows. Development/review content remains `REVIEW_REQUIRED`; the catalog projection is read-only and the audited reviewer workflow cannot manufacture ACCEPTED/GOLD state.

An authorized clinical/data-governance process must create signed approval evidence tied to canonical row/source identifiers. Re-run the production importer and emergency/retrieval acceptance suites only after that artifact exists. Until then `DATA_APPROVED=false` and production import/runtime remain fail closed.

## V4 update — 2026-08-03

Commit `367105f` adds an RBAC-protected claim/release/decision workflow, mandatory rationale, optimistic concurrency, immutable decision records and distinct second review for safety-critical items. It deliberately produces only `ELIGIBLE_FOR_GOVERNANCE_REVIEW` reports with `production_approved=false`; it does not change source rows to ACCEPTED/GOLD. No authorized reviewer acted in this session, so this external blocker remains active.

V5 hardens package import so it is atomic and rejects immutable-evidence replay mismatches, prioritizes safety/adjudication work, and adds deterministic PHI-safe evidence-package digests. The remaining blocker is external and deliberate: there is no signed chain-of-custody bridge from review evidence to an approved production manifest, and no real authorized reviewer has completed the required scope. See `docs/runbooks/CLINICAL_REVIEW_OPERATIONS.md`.
